Early Phase 1 Peripheral Arterial Disease Trial, Recruiting NCT03529019 Sponsor: Boston Medical Center Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Early Phase 1 Peripheral Arterial Disease Trial, Recruiting

NCT03529019
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Critical Limb Ischemia (a severe condition where not enough blood reaches the limbs, usually the legs or feet)

Who may not be able to join:

  • Women who are currently pregnant or breastfeeding
  • People who have been diagnosed with advanced kidney disease (classified as Stage 4 or Stage 5)
  • People who are currently receiving dialysis (a treatment that does the work of the kidneys when they can no longer function properly)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Jeffrey J Siracuse, MD, Boston Medical Center

Phone: 617-638-8488

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Boston Medical Center
Registry
ClinicalTrials.gov
Start date
2 October 2018
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in serum albumin levels; Change in prealbumin levels; Change in transferrin levels; Change in C-reactive protein levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov